AAAAAA

   
Results: 1-6 |
Results: 6
Mutation analysis of the FAS and TNFR apoptotic cascade genes in hematological malignancies
Authors: Rozenfeld-Granot, G Toren, A Amariglio, N Brok-Simoni, F Rechavi, G
Citation: G. Rozenfeld-granot et al., Mutation analysis of the FAS and TNFR apoptotic cascade genes in hematological malignancies, EXP HEMATOL, 29(2), 2001, pp. 228-233
Subgroup of patients with Philadelphia-positive chronic myelogenous leukemia characterized by a deletion of 9q proximal to ABL gene: expression profiling, resistance to interferon therapy, and poor prognosis
Authors: Cohen, N Rozenfeld-Granot, G Hardan, I Brok-Simoni, F Amariglio, N Rechavi, G Trakhtenbrot, L
Citation: N. Cohen et al., Subgroup of patients with Philadelphia-positive chronic myelogenous leukemia characterized by a deletion of 9q proximal to ABL gene: expression profiling, resistance to interferon therapy, and poor prognosis, CANC GENET, 128(2), 2001, pp. 114-119
Nonmuscle myosin heavy chain IIA mutations define a spectrum of autosomal dominant macrothrombocytopenias: May-Hegglin anomaly and Fechtner, Sebastian, Epstein, and Alport-like syndromes
Authors: Heath, KE Campos-Barros, A Toren, A Rozenfeld-Granot, G Carlsson, LE Savige, J Denison, JC Gregory, MC White, JG Barker, DF Greinacher, A Epstein, CJ Glucksman, MJ Martignetti, JA
Citation: Ke. Heath et al., Nonmuscle myosin heavy chain IIA mutations define a spectrum of autosomal dominant macrothrombocytopenias: May-Hegglin anomaly and Fechtner, Sebastian, Epstein, and Alport-like syndromes, AM J HU GEN, 69(5), 2001, pp. 1033-1045
Amplification of immunological functions by subcutaneous injection of intermediate-high dose interleukin-2 for 2 years after autologous stem cell transplantation in children with stage IV neuroblastoma
Authors: Toren, A Nagler, A Rozenfeld-Granot, G Levanon, M Davidson, J Bielorai, B Kaplinsky, C Meitar, D Mandel, M Ackerstein, A Ballin, A Attias, D Biniaminov, M Rosenthal, E Brok-Simoni, F Rechavi, G Kaufmann, Y
Citation: A. Toren et al., Amplification of immunological functions by subcutaneous injection of intermediate-high dose interleukin-2 for 2 years after autologous stem cell transplantation in children with stage IV neuroblastoma, TRANSPLANT, 70(7), 2000, pp. 1100-1104
Autosomal-dominant giant platelet syndromes: a hint of the same genetic defect as in Fechtner syndrome owing to a similar genetic linkage to chromosome 22q11-13
Authors: Toren, A Rozenfeld-Granot, G Rocca, B Epstein, CJ Amariglio, N Laghi, F Landolfi, R Brok-Simoni, F Carlsson, LE Rechavi, G Greinacher, A
Citation: A. Toren et al., Autosomal-dominant giant platelet syndromes: a hint of the same genetic defect as in Fechtner syndrome owing to a similar genetic linkage to chromosome 22q11-13, BLOOD, 96(10), 2000, pp. 3447-3451
Genetic linkage of autosomal-dominant Alport syndrome with leukocyte inclusions and macrothrombocytopenia (Fechtner syndrome) to chromosome 22q11-13
Authors: Toren, A Amariglio, N Rozenfeld-Granot, G Simon, AJ Brok-Simoni, F Pras, E Rechavi, G
Citation: A. Toren et al., Genetic linkage of autosomal-dominant Alport syndrome with leukocyte inclusions and macrothrombocytopenia (Fechtner syndrome) to chromosome 22q11-13, AM J HU GEN, 65(6), 1999, pp. 1711-1717
Risultati: 1-6 |